Cargando…
Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
Immunotherapy is a vital treatment for patients with cutaneous melanoma (CM), but effective predictors to guide clinical immunotherapy are lacking. Cuproptosis is a newly discovered mode of cell death related to tumorigenesis. Exploring the relationship between the mode of cuproptosis and the effect...
Autores principales: | Liu, Da, Yang, Fan, Zhang, Tongtong, Mao, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885583/ https://www.ncbi.nlm.nih.gov/pubmed/36717900 http://dx.doi.org/10.1186/s12967-023-03891-4 |
Ejemplares similares
-
Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022) -
Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
por: Zhao, Yi, et al.
Publicado: (2023) -
Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022) -
A Newly Established Cuproptosis-Related Gene Signature for Predicting Prognosis and Immune Infiltration in Uveal Melanoma
por: Huang, Wei, et al.
Publicado: (2023) -
Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases
por: Ma, Qi, et al.
Publicado: (2022)